Protective fibroblastic niches in secondary lymphoid organs.
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
01 Jan 2024
01 Jan 2024
Historique:
received:
18
09
2023
revised:
20
11
2023
accepted:
21
11
2023
medline:
4
12
2023
pubmed:
1
12
2023
entrez:
1
12
2023
Statut:
ppublish
Résumé
Fibroblastic reticular cells (FRCs) are specialized fibroblasts of secondary lymphoid organs that provide the structural foundation of the tissue. Moreover, FRCs guide immune cells to dedicated microenvironmental niches where they provide lymphocytes and myeloid cells with homeostatic growth and differentiation factors. Inflammatory processes, including infection with pathogens, induce rapid morphological and functional adaptations that are critical for the priming and regulation of protective immune responses. However, adverse FRC reprogramming can promote immunopathological tissue damage during infection and autoimmune conditions and subvert antitumor immune responses. Here, we review recent findings on molecular pathways that regulate FRC-immune cell crosstalk in specialized niches during the generation of protective immune responses in the course of pathogen encounters. In addition, we discuss how FRCs integrate immune cell-derived signals to ensure protective immunity during infection and how therapies for inflammatory diseases and cancer can be developed through improved understanding of FRC-immune cell interactions.
Identifiants
pubmed: 38038708
pii: 276440
doi: 10.1084/jem.20221220
pmc: PMC10691961
pii:
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss National Science Foundation
ID : 177208
Pays : Switzerland
Informations de copyright
© 2023 De Martin et al.
Références
Annu Rev Immunol. 2021 Apr 26;39:557-581
pubmed: 33651964
Surg Radiol Anat. 2014 Dec;36(10):1051-5
pubmed: 24435023
Mol Immunol. 1987 Jul;24(7):675-97
pubmed: 3498884
Nat Cell Biol. 2022 Apr;24(4):565-578
pubmed: 35332263
Cancers (Basel). 2021 Jan 08;13(2):
pubmed: 33430113
Nat Immunol. 2016 Sep;17(9):1118-27
pubmed: 27400148
J Exp Med. 2010 Apr 12;207(4):689-97
pubmed: 20308362
J Clin Invest. 2017 Apr 3;127(4):1574-1588
pubmed: 28319044
Nature. 2018 Feb 22;554(7693):475-480
pubmed: 29443965
Immunol Rev. 1990 Jun;115:11-147
pubmed: 2202659
Sci Immunol. 2018 Aug 10;3(26):
pubmed: 30097537
Nature. 2007 Nov 1;450(7166):110-4
pubmed: 17934446
Blood. 2010 Jun 10;115(23):4725-33
pubmed: 20185585
Nat Immunol. 2019 Dec;20(12):1668-1680
pubmed: 31636464
PLoS Biol. 2018 Sep 4;16(9):e2005046
pubmed: 30180168
Eur J Immunol. 2022 Jun;52(6):895-906
pubmed: 35365883
Nat Immunol. 2023 Jul;24(7):1124-1137
pubmed: 37217705
J Exp Med. 2022 May 2;219(5):
pubmed: 35315876
J Immunol. 2003 Aug 1;171(3):1148-55
pubmed: 12874200
Immunol Rev. 1997 Apr;156:11-24
pubmed: 9176696
Cancer Immunol Res. 2022 Apr 1;10(4):482-497
pubmed: 35362044
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
JCI Insight. 2022 Nov 22;7(22):
pubmed: 36227687
Immunity. 2020 May 19;52(5):794-807.e7
pubmed: 32298648
J Clin Invest. 2022 Jul 1;132(13):
pubmed: 35775481
Immunology. 1965 Oct;9(4):333-48
pubmed: 5844809
Immunity. 2007 Jul;27(1):160-71
pubmed: 17658276
Blood. 2012 Dec 6;120(24):4675-83
pubmed: 22955921
Immunity. 2019 Aug 20;51(2):337-350.e7
pubmed: 31375460
Annu Rev Immunol. 2008;26:741-66
pubmed: 18173374
Nat Commun. 2020 Jul 22;11(1):3677
pubmed: 32699279
Nat Commun. 2018 Sep 25;9(1):3903
pubmed: 30254319
J Exp Med. 2018 Dec 3;215(12):2972-2983
pubmed: 30429248
Sci Immunol. 2020 Sep 11;5(51):
pubmed: 32917792
Immunology. 2014 Nov;143(3):462-77
pubmed: 24890772
Nat Immunol. 2007 Nov;8(11):1255-65
pubmed: 17893676
Cell Rep. 2020 Jan 21;30(3):893-904.e6
pubmed: 31968261
PLoS Biol. 2016 Jul 14;14(7):e1002515
pubmed: 27415420
J Exp Med. 1951 Feb;93(2):173-88
pubmed: 14803641
Eur J Immunol. 2021 Jan;51(1):76-90
pubmed: 32700362
Immunity. 2023 Jun 13;56(6):1204-1219.e8
pubmed: 37160119
J Immunol. 2002 Jun 15;168(12):6032-40
pubmed: 12055211
Immunol Rev. 2021 Jul;302(1):32-46
pubmed: 34046914
J Exp Med. 2018 Nov 5;215(11):2760-2777
pubmed: 30355615
Nat Immunol. 2021 Apr;22(4):510-519
pubmed: 33707780
Nat Immunol. 2021 May;22(5):571-585
pubmed: 33903764
Trends Cell Biol. 2022 Apr;32(4):324-337
pubmed: 34657762
Immunity. 2021 Oct 12;54(10):2256-2272.e6
pubmed: 34555336
Annu Rev Biomed Eng. 2016 Jul 11;18:207-33
pubmed: 26928210
Nat Immunol. 2019 May;20(5):534-545
pubmed: 30962593
J Immunol. 1998 Jun 1;160(11):5273-9
pubmed: 9605124
Immunol Rev. 2016 May;271(1):200-20
pubmed: 27088916
Nature. 2006 Apr 13;440(7086):890-5
pubmed: 16612374
Nat Immunol. 2022 Aug;23(8):1169-1182
pubmed: 35882934
Nat Immunol. 2022 Aug;23(8):1246-1255
pubmed: 35817845
Annu Rev Immunol. 2016 May 20;34:203-42
pubmed: 26907216
Immunity. 2013 Apr 18;38(4):782-91
pubmed: 23601687
J Immunol. 2007 Jun 15;178(12):7747-55
pubmed: 17548612
Nat Commun. 2020 Jan 24;11(1):519
pubmed: 31980640
Immunity. 2013 May 23;38(5):1013-24
pubmed: 23623380
J Immunol. 2012 May 1;188(9):4135-40
pubmed: 22517866
Nat Immunol. 2023 Aug;24(8):1281-1294
pubmed: 37443283
Sci Immunol. 2021 Dec 17;6(66):eaao3669
pubmed: 34919443
Front Immunol. 2017 Feb 03;8:45
pubmed: 28217126
J Immunol. 2021 Jan 15;206(2):257-263
pubmed: 33397739
Immunity. 2019 Jun 18;50(6):1467-1481.e6
pubmed: 31201093
Sci Immunol. 2019 Mar 1;4(33):
pubmed: 30824527
Science. 2015 Feb 6;347(6222):667-72
pubmed: 25657250
Immunity. 2021 Aug 10;54(8):1788-1806.e7
pubmed: 34166622
Nat Immunol. 2019 Nov;20(11):1506-1516
pubmed: 31611698
PLoS Biol. 2019 Dec 19;17(12):e3000486
pubmed: 31856185
Immunity. 2020 Jul 14;53(1):127-142.e7
pubmed: 32562599
MAbs. 2020 Jan-Dec;12(1):1729683
pubmed: 32097086
Cell Rep. 2016 May 17;15(7):1527-1541
pubmed: 27160906
Cancer Res. 2022 May 3;82(9):1774-1788
pubmed: 35502542
Nat Rev Immunol. 2008 Oct;8(10):764-75
pubmed: 18825130
Eur J Immunol. 2023 Sep;53(9):e2250355
pubmed: 36991561
Laryngoscope. 1999 Mar;109(3):368-70
pubmed: 10089959
Nat Rev Immunol. 2014 Jul;14(7):495-504
pubmed: 24948364
Blood. 2017 May 4;129(18):2507-2518
pubmed: 28202459
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6826-E6835
pubmed: 29967180
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16161-6
pubmed: 22988065
Oncoimmunology. 2020 Oct 19;9(1):1830513
pubmed: 33117603
Life Sci Alliance. 2021 Jun 29;4(8):
pubmed: 34187874
J Virol. 2002 Mar;76(5):2375-83
pubmed: 11836415
Sci Immunol. 2022 Jan 07;7(67):eabj0641
pubmed: 34995096
Nat Immunol. 2020 Jun;21(6):649-659
pubmed: 32424359
Sci Transl Med. 2023 Jun 28;15(702):eadd1175
pubmed: 37379368
Cell. 2023 Jan 5;186(1):131-146.e13
pubmed: 36565697
J Immunol Methods. 2006 May 30;312(1-2):12-9
pubmed: 16624319
Nature. 2021 May;593(7860):575-579
pubmed: 33981032
Trends Immunol. 2021 Sep;42(9):782-794
pubmed: 34362676
Nat Immunol. 2014 Oct;15(10):973-81
pubmed: 25151489
Front Immunol. 2012 Jul 12;3:200
pubmed: 22807928
Nature. 2019 Feb;566(7744):393-397
pubmed: 30664748
Nat Immunol. 2023 Jul;24(7):1138-1148
pubmed: 37202490
Immunity. 2017 Jul 18;47(1):80-92.e4
pubmed: 28709801
Eur J Immunol. 2020 Jun;50(6):846-857
pubmed: 32043573
Nat Immunol. 2016 Dec;17(12):1388-1396
pubmed: 27798617
Eur J Immunol. 1997 Oct;27(10):2626-33
pubmed: 9368619
Science. 2021 Nov 26;374(6571):1070-1075
pubmed: 34822279
Nat Commun. 2019 Apr 15;10(1):1739
pubmed: 30988302
J Exp Med. 2018 Apr 2;215(4):1227-1243
pubmed: 29549115
Nat Immunol. 2023 Jul;24(7):1149-1160
pubmed: 37202489
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12139-44
pubmed: 25092322
J Exp Med. 2014 Oct 20;211(11):2265-79
pubmed: 25311507
Oncol Lett. 2017 Sep;14(3):2954-2960
pubmed: 28928833
J Clin Invest. 2023 Jul 3;133(13):
pubmed: 37219943
Breast. 2012 Oct;21(5):615-20
pubmed: 22749923
Nat Rev Immunol. 2010 Sep;10(9):664-74
pubmed: 20706277
J Exp Med. 1996 May 1;183(5):2259-69
pubmed: 8642335
Nat Immunol. 2011 Sep 18;12(11):1096-104
pubmed: 21926986